Aegerion discloses tentative deal on drug marketing, but not on FCPA probe
MLex Summary: Aegerion Pharamaceuticals, based in Massachusetts, said in a securities filing that it has reached a preliminary agreement with US authorities to resolve a drug marketing case with guilty pleas...To view the full article, register now.
Already a subscriber? Click here to view full article